Duong Tran

@DenisRudev @todd_harrison are you worried about this 5/13 vote?

🌿 The Two-Tier U.S. Cannabis Market Is Now Real The headline most accounts are still missing: federal cannabis policy split into two tracks last week, and a May 13 vote could decide which one survives. 📋 What’s already happened: → Apr 23: DOJ Final Order places state-licensed medical cannabis into Schedule III → Apr 28: Effective on Federal Register publication → Apr 29: DEA Medical Dispensary Registration Portal goes live — $794/location, 60-day expedited window (closes Jun 26) → Apr 29: $TCNNF files first — 200+ dispensaries committed → Treasury/IRS confirm forthcoming guidance, including retrospective 280E relief under review 📊 What this means structurally: ▸ Medical operators → Schedule III, 280E-exempt for the entire 2026 tax year, federal banking/payments exposure improves ▸ Recreational operators → status quo. 280E intact. Outcome contingent on the broader ALJ proceeding ▸ Mixed operators face an expense-allocation question the IRS hasn’t answered yet 🚨 The catch most are underweighting: May 1 — House Appropriations CJS Subcommittee voted 8-6 (party-line) to advance Section 591, barring DOJ from using any funds to reschedule marijuana. Full Committee markup: May 13. Identical language was advanced and stripped in 2025. The risk isn’t zero this time. 📅 The 60-day institutional clock: → May 13: Full Appropriations Committee markup → May 24: ALJ participation notice deadline (electronic) → Jun 22: DEA notifies selected participants → Jun 29 – Jul 15: ALJ hearing on full rescheduling → Jun 26: DEA medical registration window closes 📈 Market read: $MSOS closed May 1 at $5.04. +41% on the month, +59% trailing 12-month. Net inflows of $22.9M over the past 5 days. The medical-tier win is being priced. The May 13 political risk is not. The bull case is procedural: DOJ has the record, the EO has the cover, and the hearing has firm deadlines. The bear case is institutional: a single committee vote could stall the broader proceeding regardless of executive momentum. Watch the Appropriations Committee on May 13. That vote — not last week’s order — is the next institutional tell. $MSOS $TCNNF $GTBIF $CURLF $CRLBF $VREOF #USCannabis #Rescheduling #280E #MSOGang #CannabisInvesting

@DenisRudev How likely do you think the full committee will vote for the bill?

@Mountainman1723 How would that affect medical MJ’s rescheduling to schedule iii?

SAM's lawsuit to block Medicare's CBD pilot was dying on standing. Then a company that hasn't brought a product to market in 10 years stepped in to save it MMJ International Holdings: why did they do it, and who actually loses? We dug in $MSOS $CNBS cannanews.io/article/mmj-in…

@TicTocTick What do you think about MSOS?

@TicTocTick Can you please take a look at MSOS?

Analyzed 190000 charts and 2 million head and shoulders. Did not like anything .

@JohnLoc18 I’m in the same boat, but don’t give up. We can’t. For the sake of our families

Almost killed myself after losing everything but for the sake of my family I choose to stand up and never give up.

@DenisRudev Once uplisting starts, could Msos become a meme play again? Is it too much to ask :P?

🚨 The first MSO to report Q1 2026 — Verano’s print is the cleanest read-through on what Schedule III actually means at the operator level. 60% medical mix. $20M buyback. Cheapest Tier 1 valuation. Here’s the breakdown ↓ $VRNOF $MSOS

@todd_harrison “being a legal business is a big hurdle for us to get over right now. I mean, there’s nothing in the bylaws that preclude us from being listed. It’s just the exchanges are choosing not to based on the federal illegality of the product.”

Verano Earnings + Call Notes U.S. canna leader shares results and looks ahead. #CannabisConfidential 🇺🇸🌿 /position $VRNO toddharrison.substack.com/p/verano-earni…

@BoobeeYaga @todd_harrison “When you actually start to get more approval and more acceptance at the federal level, you can imagine that it’ll just further strengthen our case. we’re keeping our head down and making sure that we’re staying very close to these institutions and not missing any opportunities.”

@todd_harrison Nothing that precludes cannabis companies from being up-listed. 👀 ^ just need the exchanges to understand / approve of the legality. $vrno $msos

@DenisRudev Need safe banking & uplisting

DEA has opened the application window for federal protections under rescheduling — turning state medical cannabis programs into something the federal government can finally study, fund, and treat like real medicine. This is the first real crack in 50+ years of Schedule I dogma, unlocking legitimate research dollars and letting science catch up to what patients and 40+ states already know works for pain, PTSD, epilepsy, and more. The real unlock: evidence-based policy that could reshape veteran care, chronic illness treatment, and even reduce opioid reliance — without waiting for Congress. With the medical side now moving, what’s the smartest next domino — SAFE banking, interstate commerce, or targeted descheduling? Drop your take below. The data is in. The plant is ready. 🌿 #USCANNABIS #CannabisRescheduling #MedicalMarijuana #EvidenceBasedPolicy

Why Markets $SPY $QQQ Stubbornly Refuse to Fall, The Invisible Hand! 👇 Markets stubbornly refuse to collapse. Oil is rising, US10Y is rising, DXY is rising, Hormuz is not fully open. Despite so much geopolitical and macro pressure, the doom callers keep drawing collapse scenarios, but the market is not fully surrendering to that. So why? Isn’t it strange? Because the real fuel of markets is not news, it is liquidity. Let me tell you what is happening behind the curtain, because you cannot find the truth anywhere else! There is no real work behind the posts of the doom callers. The Fed ended balance sheet reduction (QT) as of December 1 and immediately after that started Reserve Management Purchases (RMP) on December 10. The purpose is not to provide economic stimulus; it is to prevent repo market rates from getting out of control and to keep reserves in the banking system at ample levels. The technical name may be different, but the result is clear: the Fed’s balance sheet has started growing again. This is not classic QE. But if the balance sheet is growing and system liquidity is increasing, from the market’s perspective, its effect creates QE like support. The Fed does not call this QE because the official purpose is not economic expansion, but protecting market functioning. However, in practice, through T-bill purchases, around $40B in monthly net liquidity support is being provided to the system, and this prevents possible stress in the repo market from growing. The second leg of the story is the Treasury side. The Treasury’s buyback program is active. In other words, the Treasury supports the functioning of the bond market by buying back illiquid bonds it issued in the past. Technically, this is not QE because it is done by the Treasury, not the central bank. But in terms of market impact, it creates a liquidity friendly result. Here too, an additional support of around $12-13B per month is formed. So when the Fed and Treasury are considered together, there is more than $52B in monthly liquidity injection into the system. This means massive support of more than $600B on an annual basis. That is why the market does not collapse easily. Oil can rise. Bond yields can rise. DXY can strengthen. Geopolitical risks can increase. But as long as the system is not completely left without water, the market finds buyers again on every dip. Because the market prices liquidity. That is the real issue. Sometimes the market does not care about the economy, it cares about whether the tap is open. Right now, the tap is not only open, it is flowing heavily. And that is why, even though disaster scenarios are constantly discussed, the market still finds a way to go higher. I do not ask for things like this, but I would appreciate it if you repost and like it. Otherwise, I only make this kind of post on Patreon-X Subscribe. If you create motivation for me, I can continue. I can say almost no one knows the main metric behind $BTC either. But I cannot share that here either. Thank you in advance. Let me say this openly as well. Unfortunately, I cannot find the support I am looking for on X. People say if they get 500-1,000 likes, they will do this or that, but what they do is not really important. If I cannot find the support I am looking for again, this may be my last post on critical topics. Because it makes me feel like I am rowing for nothing

@fila_thoma55765 Hi man, it’s Duong. I’m ok. Couldn’t text you, not sure why. All messages failed to send

Lost technical support . This news yesterday was a killer . It’s going down to $0.85

@MichaelPBento Can’t wait till that day! So sick of all the manipulation

All of you celebrating this insane price action because “just go long” and getting on me for calling for a pullback don’t understand that I want a pullback because it’s a healthy sign for the market, right now, this price action is what we saw at the end of the last couple of cycles, and I guarantee you the day it crashes you will caught off guard and lose 95% in a day. Playing chicken with a freight train is all fun and games until it runs you down. A lot of you have never traded during a real limit down, and I promise you will experience that soon.

@DenisRudev I thought the Treasury notice already said no retroactive relief beyond 1/1/26?

🇺🇸 DAY 1 OF SCHEDULE III. THE DEA REGISTRATION PORTAL IS LIVE. The Federal Register published the DOJ Final Order yesterday (April 28). Medical cannabis is now Schedule III. §280E relief backdated to April 22. This morning at 9:00 AM ET, the DEA Medical Marijuana Dispensary Registration Portal opens. $794 annual application fee. State licensees who file within 60 days (by ~June 27) get expedited review and protected operating continuity under their state licenses while DEA reviews. MGO out with a sharp operator advisory framing the compliance pathway. The investor translation: ▪️ EXECUTION BIFURCATION Operators who file fast get expedited Schedule III review and continuity protection. Laggards face open-ended timelines and operational risk. Filing velocity over the next 60 days will be a real-time read on management quality across the MSO complex. ▪️ §280E LOOKBACK OPTIONALITY — UNPRICED The DOJ order explicitly encouraged Treasury to consider retrospective §280E relief. Whitney Economics estimates the operator base has paid ~$15B in excess 280E-related federal taxes since 2018. Treasury & IRS have acknowledged the issue but issued no guidance yet. If they move on lookback, the refund stack could run multi-billion across MSOs. ▪️ JUNE 29 IS THE STRUCTURAL CATALYST DEA’s broader rescheduling hearing (adult-use → Schedule III) must conclude by July 15. Until then, §280E relief is capped to the medical sleeve of operator revenue. Adult-use stays Schedule I on the clock. 📅 KEY DATES: → Today (Apr 29): DEA registration portal opens, 9:00 AM ET → May 28: hearing participation notice deadline → June 22: DEA notifies selected hearing participants → ~June 27: 60-day expedited registration window closes → June 29 – July 15: broader rescheduling hearing Medical cannabis is a federally legitimate Schedule III product for the first time in 55 years. The adult-use sleeve is still on the clock. $MSOS $TCNNF $CURLF $GTBIF $CRLBF $VREOF #USCannabis #Rescheduling #280E #MSOGang #CannabisInvesting

@AMartinelliWA That’s good news for MSOS right?

Neither of the hemp-related amendments to the 2026 farm bill (one to delay the federal ban by a year and one to speed it up) will be given approval by the House Rules Committee, leaving the November ban in place (at least for now).

@pdicarlotrader Are you still positive on ENPH?

$ENPH building a base in the loading zone. Monthly BX is in a bull cycle. Historically, this area marks the bottom 75% of the time. I’m looking for a move toward 50 over the next 90–120 days if this zone holds.